Back

BMP9 attenuates IL-33 signaling and prevents endothelial-to-mesenchymal transition in pulmonary arterial hypertension

12 April 2024 (17:15 - 17:30)
Organised by: Logo
Congress Presentation Part of: The matrix resurrected and reloaded Hypertension, Pulmonary Hypertension CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Miss Clarissa Becher

Leiden University Medical Center, Leiden (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Matrix profiling in atherosclerosis
Professor M. Mayr (London, GB)
Slides
Presentation thumbnail
Matrix in cardiac repair and regeneration
Doctor C. Balbi (Zurich, CH)
Slides
Presentation thumbnail
Mechanotransduction in valve development and disease
Doctor M. Pesce (Casamassima, IT)
Slides

Access the full session

Session thumbnail
The matrix resurrected and reloaded

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Increased bone morphogenetic protein 10 in precapillary pulmonary hypertension patients
12 April 2024
thumbnail
Congress Presentation
Interleukin-1B and ST2L/IL-33R and risk of clinical outcomes in patients with multi-vessel disease
31 August 2025
thumbnail
Congress Presentation
Long noncoding RNA H19 is elevated in aortic valve stenosis and governs antigenic response and valvular endothelial cell phenotypes through endothelial to mesenchymal transition
26 August 2023
thumbnail
Congress Presentation
Vascular endothelial growth factor C as a potential biomarker of peripheral tissue congestion in acute heart failure.
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources